Physician profile
Lewis Rosenberg
NPI 1386720910
$9,363.04
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,589 · 2020: $4,416 · 2021: $380 · 2022: $552 · 2023: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $426.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $7,415.06 | 2019-2020 | |
| Abbvie INC. | $794.93 | 2019-2023 | Qulipta, Ubrelvy |
| Amgen INC. | $559.20 | 2019-2023 | Prolia, Evenity |
| Sumitomo Pharma America, INC. | $125.00 | 2023 | Myfembree |
| Lupin INC. | $124.72 | 2019-2020 | |
| Hologic Sales and Service, LLC | $49.40 | 2021-2022 | |
| Myovant Sciences INC. | $38.36 | 2022 | |
| Pfizer INC. | $35.53 | 2020-2022 | |
| Agile Therapeutics, INC. | $35.12 | 2023 | Twirla |
| Organon LLC | $35.03 | 2022 | |
| Scynexis, INC. | $31.62 | 2022 | |
| Meditrina | $28.24 | 2021 | |
| Avion Pharmaceuticals | $22.28 | 2022 | |
| Amarin Pharma, INC. | $20.34 | 2020 | |
| Duchesnay USA Incorporated | $17.82 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $15.59 | 2022 | |
| Therapeuticsmd, INC. | $14.80 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lewis Rosenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.